Renal Involvement in Sjogren S Syndrome

1. H. Murata, Y. Kita, A. Sakamoto et al., “Limited TCR repertoire of infiltrating T cells in the kidneys of Sjögren’s syndrome patients with interstitial nephritis,” The Journal of Immunology, vol. 155, no. 8, pp. 4084-4089, 1995. Search in Google Scholar

2. Y. Itoh, K. Kin, T. Kasahara et al., “Synthesis and secretion of alpha 1-microglobulin by human lymphocytes”, Clinical & Experimental Immunology, vol. 37, no. 1, pp. 134-139, 1979. Search in Google Scholar

3. Quin B, Wang J, Yangz, et al. Epidemiology of primary Sjogren’s syndrome a systematic review and meta-analysis. Ann Rheum Dis. 2015; 74(11):1983-1989.10.1136/annrheumdis-2014-205375 Search in Google Scholar

4. Fox RI, Stern M, Michelson P. Update in Sjogren’s. Curr Opin Rheumatol.2000; 12(5) :391-398.10.1097/00002281-200009000-00007 Search in Google Scholar

5. Manthorpe R, Oxholm P, Prause JU, Schiødt M. The Copenhagen criteria for Sjögren’s syndrome. Scand J Rheumatol Suppl. 1986; 61:19-21. Search in Google Scholar

6. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002; 61:554-558.10.1136/ard.61.6.554 Search in Google Scholar

7. Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Col-laborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012; 64:475-48710.1002/acr.21591 Search in Google Scholar

8. Baldini C, Talarico R, Tzioufas AG, Bombardieri S. Classification criteria for Sjogren’s syndrome: a critical review. J Autoimmun. 2012;39: 9-14.10.1016/j.jaut.2011.12.006 Search in Google Scholar

9. Fox RI, Liu AY: Sjögren’s syndrome in dermatology. Clin Dermatol, 2006; 24(5): 393-413.10.1016/j.clindermatol.2006.07.005 Search in Google Scholar

10. Fox RI. Sjogren’s syndrome. Lancet.2005; 366 (9482): 321-331.10.1016/S0140-6736(05)66990-5 Search in Google Scholar

11. Ramos- Casals M, Brito-Zeron P, Font J. The overlap of for Sjogren’s syndrome with other systemic autoimmune diseases. Semin Arhtritis Rheum. 2007; 36(4):246-255.10.1016/j.semarthrit.2006.08.00716996579 Search in Google Scholar

12. Strombeck B, Ekdahe C, Manthorpe R, et al. Health-related quality of life in primary Sjogren’s syndrome, rheumatoid and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol. 2000; 29(1):20-28.10.1080/03009740075000176110722254 Search in Google Scholar

13. Theander E, Jacobsson LTH: Relationship of Sjögren’s syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am, 2008; 34(4): 935-47.10.1016/j.rdc.2008.08.00918984413 Search in Google Scholar

14. Goules A V, Tatouli IP, Moutsopoulos HM, Tzioufas AG: Clinically significant renal involvement in primary Sjögren’s syndrome: Clinical presentation and outcome. Arthritis Rheum, 2013; 65(11): 2945-53.10.1002/art.38100 Search in Google Scholar

15. Lim AKH, Choi MJ: Distal renal tubular acidosis associated with Sjögren syndrome. Intern Med J, 2013; 43(12): 1330-34.10.1111/imj.12300 Search in Google Scholar

16. François H, Mariette X: Renal involvement in primary Sjögren syndrome. Nat Rev Nephrol, 2016; 12(2): 82-93.10.1038/nrneph.2015.174 Search in Google Scholar

17. M. Jallouli, M. Frigui, S. Marzouk et al., “Osteomalacia revealing Sjögren’s syndrome: a case report,” La Revue de Médecine Interne, vol. 29, no. 4, pp. 311-314, 2008.10.1016/j.revmed.2007.09.028 Search in Google Scholar

18. Goules A, Masouridi S, Tziofas AG, Ioannidis JPA, Skopouli FN, Moutsopoulos HM. Clinically significant and biopsy documented renal involvement in primary Sjögren syndrome. Medicine, 2000;79:241-249.10.1097/00005792-200007000-00005 Search in Google Scholar

19. Rosenberg ME, Schendel PB, McCurdy FA, Platt JL. Characterization of immune cells in kidneys from patients with Sjögren syndrome. A J Kidney Dis 1988;11:20-22.10.1016/S0272-6386(88)80169-0 Search in Google Scholar

20. Siamopoulos H M, Drosos A. Mavridis A, Moutsopoulos HM. Renal tubular acidosis in primary Sjogren’s syndrome, Clin Reumatol 1992; 11:1-5 Search in Google Scholar

21. Moutsopoulos HM, C;edes J, Skopouli FN, Elisaf M, Youinoi P. Nephrocalcinosis in Sjogren’s syndrome; a late sequela of renal tubular acidosis. J Inter Med 1991; 230:187-191.10.1111/j.1365-2796.1991.tb00429.x Search in Google Scholar

22. Lim AKH, Choi MJ: Distal renal tubular acidosis associated with Sjögren syndrome. Intern Med J, 2013; 43(12): 1330-3410.1111/imj.12300 Search in Google Scholar

23. Skopouli FN, Dafni U, Ioannidis JPA, Moutsopoulos HM. Clinical evolution and morbidity and mortality of primary Sjogren’s syndrome. Semin Arthritis Rheum 2000; 29:296-304.10.1016/S0049-0172(00)80016-5 Search in Google Scholar

24. Dowd JE, Lipsky PE. Sjogren’s syndrome presenting as hypokalemic periodic paralysis. Arthritis Rheum 1993;12:1735-1738. Search in Google Scholar

25. Pal B, Griffiths ID. Primary Sjogren’s syndrome presenting as osteomalacia secondary to renal tubular acidosis. Br J Clin Practice 1988; 42:436-438. Search in Google Scholar

26. Daghestani L, Pomeroy c. renal manifestation of hepatitis C infection. AM J Med 1999; 106:347-354.10.1016/S0002-9343(99)00014-5 Search in Google Scholar

27. Maripuri S, Grande JP, Osborn TG et al: Renal involvement in primary Sjögren’s syndrome: A clinicopathologic study. Clin J Am Soc Nephrol, 2009; 4(9): 1423-3113.10.2215/CJN.00980209273668919679669 Search in Google Scholar

28. Evans R, Zdebik A, Ciurtin C, Walsh SB: Renal involvement in primary Sjögren’s syndrome. Rheumatology (Oxford), 2015; 54(9): 1541-4814.10.1093/rheumatology/kev22326070939 Search in Google Scholar

29. Goules A V, Tatouli IP, Moutsopoulos HM, Tzioufas AG: Clinically significant renal involvement in primary Sjögren’s syndrome: Clinical presentation and outcome. Arthritis Rheum, 2013; 65(11): 2945-53.10.1002/art.3810024166794 Search in Google Scholar

30. Thanou-Stavraki A, James JA: Primary Sjögren’s syndrome: Current and pro-spective therapies. Semin Arthritis Rheum, 2008; 37(5): 273-9217.10.1016/j.semarthrit.2007.06.00217714766 Search in Google Scholar

31. Tishler M, Yaron I, Shirazi I, Yaron M: Hydroxychloroquine treatment for primary Sjögren’s syndrome: Its evet on salivary and serum inflammatory markers. Ann Rheum Dis, 1999; 58: 253-56.10.1136/ard.58.4.253175286510364906 Search in Google Scholar